Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Recommendation of “Hold” from Brokerages

by · The Markets Daily

Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) have been given a consensus rating of “Hold” by the sixteen analysts that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and five have given a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $7.5357.

TDOC has been the subject of several recent research reports. Bank of America increased their price target on Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a report on Tuesday, July 7th. Citigroup decreased their target price on Teladoc Health from $11.00 to $7.50 and set a “neutral” rating for the company in a research report on Monday, August 3rd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, August 19th. Finally, Canaccord Genuity Group reduced their price target on Teladoc Health from $11.00 to $10.00 and set a “buy” rating on the stock in a research report on Thursday, July 30th.

Read Our Latest Analysis on Teladoc Health

Teladoc Health Stock Performance

TDOC opened at $6.51 on Tuesday. Teladoc Health has a 1 year low of $4.40 and a 1 year high of $9.89. The firm has a 50 day moving average price of $7.94 and a 200 day moving average price of $6.64. The company has a market cap of $1.18 billion, a PE ratio of -6.58 and a beta of 2.12.

Teladoc Health (NYSE:TDOC – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.25) by $0.04. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. The company had revenue of $606.93 million during the quarter, compared to the consensus estimate of $615.44 million. During the same period in the previous year, the firm earned ($0.19) earnings per share. Teladoc Health’s revenue for the quarter was down 4.0% on a year-over-year basis. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. On average, sell-side analysts predict that Teladoc Health will post -0.89 earnings per share for the current year.

Insider Activity

In other news, insider Fernando M. Rodrigues sold 5,677 shares of Teladoc Health stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $43,315.51. Following the sale, the insider directly owned 9,572 shares of the company’s stock, valued at approximately $73,034.36. The trade was a 37.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Charles Divita III sold 19,132 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total value of $145,977.16. Following the completion of the transaction, the chief executive officer owned 389,894 shares in the company, valued at approximately $2,974,891.22. This trade represents a 4.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 39,195 shares of company stock worth $299,058. 0.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently bought and sold shares of the business. Allworth Financial LP purchased a new position in shares of Teladoc Health during the 2nd quarter valued at approximately $25,000. Twin Lakes Capital Management LLC acquired a new stake in Teladoc Health in the second quarter valued at $26,000. Nykredit A S bought a new position in Teladoc Health during the 2nd quarter valued at $27,000. IFP Advisors Inc boosted its stake in Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 3,210 shares during the last quarter. Finally, EFG International AG acquired a new position in Teladoc Health during the 2nd quarter worth $35,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.

Featured Articles